C-8XTIimmune restoration, stem cell therapy, parabiosis
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Develop an immune restoration treatment for age-related diseases using autologous mobilized peripheral blood cells.
Autologous mobilized peripheral blood cell therapy evaluated in Phase II studies at the Okyanos Center for Regenerative Medicine in Freeport, Bahamas.
Described as the lead therapy in Phase II studies at the Okyanos Center for Regenerative Medicine.
Identify youthful restorative factors and improve aging stem cell and immune cell function for age-related disease treatment discovery.
Parabiosis-inspired Transwell cell culture system used to study interactions between youthful and aged cells and identify restorative factors.
Described as Rejenevie Therapeutics' core approach supporting immune restoration treatments and pipeline discovery.
Pipeline program associated with Rejenevie Therapeutics' immune restoration and stem cell restoration approach for age-related disease.
Not disclosed in the supplied material beyond pipeline listing.
Listed in Rejenevie Therapeutics' product pipeline.
Pipeline program associated with Rejenevie Therapeutics' immune restoration and stem cell restoration approach for age-related disease.
Not disclosed in the supplied material beyond pipeline listing.
Listed in Rejenevie Therapeutics' product pipeline.
Pipeline program associated with Rejenevie Therapeutics' immune restoration and stem cell restoration approach for age-related disease.
Not disclosed in the supplied material beyond pipeline listing.
Listed in Rejenevie Therapeutics' product pipeline.
Pipeline program associated with Rejenevie Therapeutics' immune restoration and stem cell restoration approach for age-related disease.
Not disclosed in the supplied material beyond pipeline listing.
Listed in Rejenevie Therapeutics' product pipeline.
Pipeline program associated with Rejenevie Therapeutics' immune restoration and stem cell restoration approach for age-related disease.
Not disclosed in the supplied material beyond pipeline listing.
Listed in Rejenevie Therapeutics' product pipeline.